USFDA concludes inspection of Alembic Pharma's Karkhadi facility

With five observations

Alembic Pharmaceuticals announced that United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' New Injectable Facility (F-3) located at Karkhadi from 29 January 2021 to 5 February 2021. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with 5 observations.

Powered by Capital Market - Live News